Intas Pharma files DRHP with SEBI; ChrysCapital eyes 13-14x part-exit
17 June, 2013
Ahmedabad-based Intas Pharmaceuticals Ltd has filed draft red-herring prospectus (DRHP) with the market regulator for an issue which will see ChrysCapital part-exit with over 13-14x returns, said ...
TO READ THE FULL STORY
The only platform exclusively covering Private Investments in India.
Exclusive reporting, expert analyses and commentary on PE/VC/M&A deals and dealmakers
Daily, weekly and monthly curated newsletters on the alternative investment ecosystem in India
Participation in VCCircle Marquee events at concessional rates
Latest VCCEdge annual, quarterly and industry reports
Comprehensive | Accurate | Unbiased | Impeccably sourced